Fentanyl Patch Lawsuits Website Launched Heygood, Orr & Pearson Law Firm

Share Article

The law firm of Heygood, Orr & Pearson is announcing the launch of its new fentanyl pain patch website, Fentanyl Patch Lawsuits (http://fentanylpatchlawsuits.com/). The site will serve as a news and information resource for patients and their families whose lives have been affected by fentanyl prescriptions.

Thousands of patients died every year as a result of accidental overdoses caused by fentanyl or other opioid painkillers.

The law firm of Heygood, Orr & Pearson is announcing the launch of its new fentanyl pain patch website, Fentanyl Patch Lawsuits (http://fentanylpatchlawsuits.com/). The site will serve as a news and information resource for patients and their families whose lives have been affected by fentanyl prescriptions.

Fentanyl is an extremely powerful opioid painkiller—about 80-100 times more potent than morphine. Fentanyl patches are sold under the brand name Duragesic. Several companies, including Mylan, Watson, Actavis, and Tevas, sell generic fentanyl patches. Fentanyl also comes in a lollipop known as Actiq, a sublingual tablet marketed as Abstral, or a nasal spray called Lazanda.

Because of its high potency, fentanyl is only intended for long term use by opioid tolerant patients who have already undergone treatment with other types of painkillers, including cancer patients. A July 2007 safety alert by the Food and Drug Administration warned against prescribing fentanyl to patients with short terms pain, patients with post-operative pain, and patients with breathing problems because of the risk of overdose or other complications.

Fentanyl can also be extremely dangerous when prescribed to patients who are taking other drugs that depress the central nervous system, according to a warning by the CDC. When patients who are taking CNS depressant medications are treated with fentanyl, they are at risk of suffering a combined drug overdose due to the interaction of fentanyl with other prescriptions.

The FDA safety alert also warned about the risk of death from accidental overdoses caused by the side effects of fentanyl. Doctors who prescribe fentanyl products to patients who are not eligible to take the drug, or who prescribe fentanyl to patients who are taking medications that could lead to a combined drug overdose, may be putting their health—and even their lives—at risk.

If you or a loved one were the victim of a fentanyl overdose, you may be eligible to file a lawsuit against the doctor or hospital that prescribed this medication and seek compensation for your injuries. At Heygood, Orr & Pearson, we believe that when a doctor or hospital commits medical malpractice by wrongfully prescribing powerful opioids such as fentanyl to their patients, they should be held accountable in a court of law.

For a free legal consultation and to find out if you are eligible to file a fentanyl lawsuit, contact the attorneys at Heygood, Orr & Pearson by calling toll-free at 1-877-446-9001, or by sending us an email at info(at)hop-law.com.

About Heygood, Orr & Pearson

The lawyers at Heygood, Orr & Pearson (http://hop-law.com/) have represented hundreds of individuals in cases involving personal injury, wrongful death, commercial litigation, and business disputes. Our attorneys have tried over 200 cases to verdict, and have achieved verdicts and settlements for our clients totaling more than $200 million.

In addition to individuals who were injured by fentanyl, our law firm also represents clients in product and pharmaceutical liability cases involving Actos bladder cancer; SSRI antidepressants; opioid painkillers such as hydrocodone, methadone, and oxycodone; transvaginal mesh; Pradaxa; and table saw injuries. We also handle cases involving other areas of law, including lawsuits involving commercial disputes, contract claims, qui tam whistleblower claims, intellectual property disputes, and other business and injury claims.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jim Orr
Follow us on

Media